(Q74769093)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9659525%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

review article

1 reference

title

Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9659525%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

A Gillissen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9659525%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

D Nowak

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9659525%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 April 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9659525%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9659525%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9659525%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9659525%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

609-623

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9659525%20AND%20SRC:MED&resulttype=core&format=json

Oxygen-derived species: their relation to human disease and environmental stress

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Long-lived oxidants generated by human neutrophils: characterization and bioactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

LXXIII.—Oxidation of tartaric acid in presence of iron

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Oxygen radicals, cytokines, adhesion molecules, and lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Potential molecular mechanisms of oxidant-induced carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Cytokines of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Molecular basis for tumor necrosis factor-induced increase in pulmonary superoxide dismutase activities

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Arachidonic acid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Induction of pulmonary Mn superoxide dismutase mRNA by interleukin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Pulmonary oxygen toxicity. Early reversible changes in human alveolar structures induced by hyperoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

In vivo antioxidant gene expression in human airway epithelium of normal individuals exposed to 100% O2

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Kinetics of pulmonary superoxide dismutase in interleukin-1-induced oxygen-tolerant rats

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Bleomycin cytotoxicity is prevented by superoxide dismutase in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Free-radical chemistry of cigarette smoke and its toxicological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

In vivo effect of lipopolysaccharide on alveolar and peritoneal macrophages of rats: superoxide anion generation and 5-lipoxygenase metabolism of arachidonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Increased expression of manganese-containing superoxide dismutase in rat lungs after inhalation of inflammatory and fibrogenic minerals

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Glutathione in bronchoalveolar lavage fluid from smokers is related to humoral markers of inflammatory cell activity

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Pulmonary strategies of antioxidant defense

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Characterization of drugs as antioxidant prophylactics

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Regulation of antioxidant enzymes 1

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Aerosolization of superoxide dismutase. Augmentation of respiratory epithelial lining fluid antioxidant screen by aerosolization of recombinant human Cu++/Zn++ superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Reactive oxygen species in living systems: source, biochemistry, and role in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Glutathione and inflammatory disorders of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Effect of ambroxol of neutrophil chemotaxis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

The inhibition of lysosomal phospholipase A from rabbit lung by ambroxol and its consequences for pulmonary surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Alterations of the endoalveolar surfactant after surgery with extracorporeal circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Elevation of glutathione levels in bovine pulmonary artery endothelial cells by N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Mechanisms of use of extracellular glutathione by lung epithelial cells and pulmonary artery endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

The metabolism of N-acetylcysteine by human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Induction of cystine transport in bovine pulmonary artery endothelial cells by sodium arsenite

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Biochemical reaction of alpha 1 antitrypsin during the substitution therapy of patients with homozygote PI-ZZ deficit

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Emphysema: the first two centuries--and beyond. A historical overview, with suggestions for future research: Part 2

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Promotion of cystine uptake and its utilization for glutathione biosynthesis induced by cysteamine and N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Pharmacokinetics of N-acetylcysteine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Pharmacokinetics of oral acetylcysteine: absorption, binding and metabolism in patients with respiratory disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Macrophage Activation by N-Acetyl-cysteine in COPD Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Failure of N-acetylcysteine to reduce low-density lipoprotein oxidizability in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Glutathione deficiency produced by inhibition of its synthesis, and its reversal; Applications in research and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Chronic bronchitis in the 1990s: up-to-date treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Lipoprotein(a) reduction by N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

N-acetylcysteine inhibits human neutrophil and monocyte chemotaxis and oxidative metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Use of N-acetylcysteine in clinical toxicology

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

The EUROSCAN study: A progress report

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

N-acetylcysteine for lung cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Effects of metabolite VIII of bromexine (Na 872) on type II epithelium of the lung: an experimental and morphological study with reference to surfactant secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Ambroxol Inhibits Na+ Absorption by Canine Airway Epithelial Cells in Culture

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

The effects of NA872 on pulmonary maturation in the fetal lamb and rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Ambroxol and simple chronic bronchitis. Effects on subjective symptoms and ventilatory function

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Clinical efficacy of ambroxol in the treatment of bronchial stasis. Clinical trial in 120 patients at two different doses

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Multicenter study on the treatment of secretory otitis media with ambroxol. Importance of a surface-tension-lowering substance

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Antioxidant properties of Ambroxol

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Protective effect of ambroxol against heat- and hydrogen peroxide-induced damage to lung lipids in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Effect of bacterial lipopolysaccharide on the content of lipid peroxidation products in lungs and other organs of mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Ambroxol inhibits interleukin 1 and tumor necrosis factor production in human mononuclear cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Ambroxol inhibits doxorubicin-induced lipid peroxidation in heart of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Influence of cationic amphiphilic drugs on the phosphatidylcholine hydrolysis by phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Ambroxol inhibits airway hyperresponsiveness induced by ozone in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

The effects of Oradexone and Ambroxol pretreatment of the oxidative sensitivity of the red blood cells in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Prevention by ambroxol of bronchopulmonary complications after upper abdominal surgery: Double-blind italian multicenter clinical study versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Ambroxol in the treatment of idiopathic respiratory distress syndrome. An interim report on a controlled double-blind multicenter study versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Characterization of antioxidant activities of pulmonary surfactant mixtures

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Inhibition of the human neutrophil respiratory burst by native and synthetic surfactant.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

A controlled trial of ambroxol in chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990506-6

7 January 2021

10.1016/S0954-6111(98)90506-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9659525%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9659525%20AND%20SRC:MED&resulttype=core&format=json